Sit Investment Associates Inc Halozyme Therapeutics, Inc. Transaction History

Sit Investment Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$33.32 - $42.1 $789,684 - $997,770	-23,700 Reduced 53.96%	20,225 $748,000
Q3 2023 Nov 13, 2023	SELL	$36.46 - $44.03 $359,131 - $433,695	-9,850 Reduced 18.32%	43,925 $1.68 Million
Q3 2022 Nov 10, 2022	BUY	$38.53 - $51.78 $475,845 - $639,483	12,350 Added 29.81%	53,775 $2.13 Million
Q4 2021 Feb 11, 2022	BUY	$31.82 - $40.75 $1.32 Million - $1.69 Million	41,425 New	41,425 $1.67 Million
Q4 2017 Jan 10, 2018	SELL	$16.75 - $20.8 $1.14 Million - $1.41 Million	-68,000 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$11.76 - $17.4 $799,680 - $1.18 Million	68,000	68,000 $1.18 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Sit Investment Associates Inc with notifications on news.